The drug bargaining game: pharmaceutical regulation in Australia
- 31 July 2004
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 23 (4) , 785-813
- https://doi.org/10.1016/j.jhealeco.2003.11.003
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A cost-effectiveness approach to drug subsidy and pricing in Australia.Health Affairs, 2001
- Does Regulation Drive Out Competition in Pharmaceutical Markets?The Journal of Law and Economics, 2000
- International comparisons of pharmaceutical prices: what do we know, and what does it mean?Journal of Health Economics, 2000
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Strategic Pricing of New PharmaceuticalsThe Review of Economics and Statistics, 1998
- Price regulation of pharmaceuticals in CanadaJournal of Health Economics, 1998
- Multilateral BargainingThe Review of Economic Studies, 1996
- The Australian Guidelines for Subsidisation of PharmaceuticalsPharmacoEconomics, 1992
- The Australian Pharmaceutical Subsidy Gambit: Transmuting Deadweight Loss and Oligopoly Rents to Consumer SurplusPublished by National Bureau of Economic Research ,1991
- Monopoly and product qualityJournal of Economic Theory, 1978